VivoSeq
Other

Pain After Surgery

1

Pipeline Programs

1

Active Trials

2

Companies Involved

Pain After Surgery is an early-stage landscape with 1 program across 2 companies. The most active players are Boehringer Ingelheim, Averitas Pharma, Inc..

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

11/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Trial Status

9

clinical trials

Completed4 · 44%
Unknown status3 · 33%
Terminated1 · 11%
Not yet recruiting1 · 11%

Trial Activity

9 trials

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)